Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Morgan

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Molecular Immunology|December 31, 2011
Characterization of a large genomic deletion in four Irish families with C7 deficiencyA D Thomas, A Orren, J Connaughton, et al.
The Journal of Experimental Medicine|July 1, 1990
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.
Journal of Neuroimmunology|May 1, 1989
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturationN J Scolding, S Frith, C Linington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1994
Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitisS J Piddlesden, M K Storch, M Hibbs, et al.
Arthritis and Rheumatism|October 23, 2001
Membrane complement regulators protect against the development of type II collagen-induced arthritis in ratsM Mizuno, K Nishikawa, O B Spiller, et al.
Journal of the Neurological Sciences|February 1, 1989
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodiesN J Scolding, B P Morgan, A Houston, et al.
Arthritis and Rheumatism|November 18, 2000
Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the ratS M Linton, A S Williams, I Dodd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP)C W van den Berg, J M Pérez de la Lastra, D Llanes, et al.
Clinical and Experimental Immunology|October 13, 2006
The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in miceB P Morgan, J Chamberlain-Banoub, J W Neal, et al.
Clinical Endocrinology|December 1, 1986
Complement component C9 in Graves' diseaseD A Oleesky, S Ratanachaiyavong, M Ludgate, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Molecular Immunology|December 31, 2011
Characterization of a large genomic deletion in four Irish families with C7 deficiencyA D Thomas, A Orren, J Connaughton, et al.
The Journal of Experimental Medicine|July 1, 1990
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.
Journal of Neuroimmunology|May 1, 1989
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturationN J Scolding, S Frith, C Linington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1994
Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitisS J Piddlesden, M K Storch, M Hibbs, et al.
Arthritis and Rheumatism|October 23, 2001
Membrane complement regulators protect against the development of type II collagen-induced arthritis in ratsM Mizuno, K Nishikawa, O B Spiller, et al.
Journal of the Neurological Sciences|February 1, 1989
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodiesN J Scolding, B P Morgan, A Houston, et al.
Arthritis and Rheumatism|November 18, 2000
Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the ratS M Linton, A S Williams, I Dodd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP)C W van den Berg, J M Pérez de la Lastra, D Llanes, et al.
Clinical and Experimental Immunology|October 13, 2006
The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in miceB P Morgan, J Chamberlain-Banoub, J W Neal, et al.
Clinical Endocrinology|December 1, 1986
Complement component C9 in Graves' diseaseD A Oleesky, S Ratanachaiyavong, M Ludgate, et al.
Pageof 25